SANOFI SA INHABER EO 2 | 76.53 / +0.66% |
Date/Time | 03/03 / 09:00 |
Chg. / Chg.(%) | 0.50 / +0.66% |
Bid | 76.29 / 100 |
Ask | 76.32 / 100 |
Open | 76.50 |
Previous Close | 76.03 |
High | 76.53 |
Low | 76.49 |
Volume [EUR] | 0.00 |
Volume [Units] | 0 |
Price fixings | 3 |
ISIN | FR0000120578 |
Security | SNW |
Exchange | Düsseldorf |
Type | Stock |
Other Exchanges
Exchange | Last | Volume | |
---|---|---|---|
Euronext - P.. | 76.32 | ![]() |
99,723 |
Cboe Europe .. | 76.29 | ![]() |
27,884 |
London Inter.. | 76.37 | ![]() |
11,569 |
Turquoise | 76.37 | ![]() |
7,777 |
TradeGate | 76.450 | ![]() |
627 |
Frankfurt | 76.5100 | ![]() |
442 |
Xetra | 76.45 | ![]() |
183 |
Borsa Italia.. | 76.33 | ![]() |
100 |
Hannover | 76.50 | ![]() |
25 |
Vienna Globa.. | 76.53 | ![]() |
0 |
Düsseldorf | 76.53 | ![]() |
0 |
Hamburg | 76.50 | ![]() |
0 |
Berlin | 76.43 | ![]() |
0 |
München | 76.49 | ![]() |
0 |
Lang & Schwa.. | 76.270 | ![]() |
|
Stuttgart | 76.500 | ![]() |
|
gettex | 76.320 | ![]() |
|
Nasdaq Other.. | 91.3000 | ![]() |
2,501 |
Cboe Europe .. | 76.41 | 3,093 | |
Cboe Europe .. | 76.43 | 2,356 | |
Borsa Italia.. | 78.20 | ![]() |
3 |
ICE Europe | Futures | ||
EUREX | Options |
News
- Revolution Medicines Reports Fourth Quarter and Year-End 2020 Financial Results and Update on Corporate Progress
03/02/2021 / 22:05 - GlobeNewswire - Kymera Therapeutics Announces First-in-Human Dose in Phase 1 Trial of KT-474, a First-in-Class IRAK4 Protein Degrader to Treat Immune-Inflammatory Diseases
03/02/2021 / 13:00 - GlobeNewswire - Translate Bio Announces Fourth Quarter and Full Year 2020 Financial Results and Highlights Recent Progress
02/25/2021 / 22:05 - GlobeNewswire - FDA approves Libtayo® (cemiplimab-rwlc) monotherapy for patients with first-line advanced non-small cell lung cancer with PD-L1 expression of ≥50%
02/22/2021 / 19:00 - GlobeNewswire - GSK, Sanofi to restart 2nd phase COVID vaccine trial
02/22/2021 / 11:52 - TeleTrader